Homocysteine in Relation to Mortality and Morbidity From Coronary Heart Disease – (02-16-04)



Homocysteine in Relation to Mortality and Morbidity From Coronary Heart Disease

Don’t quite hold your breath yet waiting for mainstream medicine to start running standard homocysteine levels. A 5x increase risk of fatal MI and a very cheap and safe method to lower levels (not to mention benefits across other disease states) does not mean we should check levels. Personally, I’m going to wait another 20 or so years until the evidence is so stacked in favor of checking homocysteine levels that we actually see to stories in our local newspapers’ health section. THEN will be the appropriate time to start checking.

Circulation — Abstracts: Zylberstein et al. 109 (5): 601 –

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Heart Disease
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”